Skip to main content
. 2018 Mar 8;3(3):2825–2836. doi: 10.1021/acsomega.7b02045

Table 4. Percentage of Recalled Kinase Ligands, Using the Three Different Fingerprints, at 1, 5, and 10% of Total Screened Databasea.

      DISTRIB_FP_300b
FRAG_FP_1024
CACTVS_881
kinase target # ligands # decoys PR1% PR5% PR10% PR1% PR5% PR10% PR1% PR5% PR10%
abl1 182 10 749 4.4 17.6 41.2 10.4 27.5 44.0 6.6 38.5 61.5
akt1 293 16 439 27.6 78.5 86.3 10.2 54.6 66.6 16.7 40.6 65.5
akt2 117 6900 28.2 70.1 79.5 22.2 59.8 74.4 19.7 42.7 66.7
braf 152 9950 11.2 16.4 35.5 34.9 51.3 63.8 12.5 29.6 40.8
cdk2 474 27 846 7.2 21.5 34.2 4.6 13.9 25.5 5.3 16.0 28.9
csf1r 166 12 149 16.3 39.2 50.0 33.1 51.8 66.3 15.7 31.9 41.0
egfr 542 35 049 45.6 76.6 82.7 50.9 79.3 86.0 27.7 63.8 75.1
fak1 100 5350 41.0 94.0 96.0 37.0 86.0 91.0 30.0 68.0 90.0
fgfr1 139 8700 11.5 32.4 51.8 0.0 10.8 25.2 9.4 36.0 45.3
igf1r 148 9300 17.6 58.8 79.1 23.6 39.2 59.5 20.9 43.9 66.9
jak2 107 6498 30.8 62.6 73.8 22.4 36.4 49.5 23.4 44.9 56.1
kit 166 10 450 5.4 7.8 10.2 3.6 22.9 38.0 6.6 20.5 31.3
kpcb 135 8697 56.3 67.4 68.9 52.6 68.1 70.4 55.6 68.1 71.9
lck 420 27 396 27.4 49.0 64.8 22.1 40.0 52.9 28.3 61.0 74.5
mapk2 101 6145 23.8 38.6 40.6 34.7 35.6 38.6 40.6 65.3 75.2
met 166 11 250 50.6 70.5 75.9 54.8 70.5 78.9 31.9 70.5 75.9
mk01 79 4547 57.0 73.4 79.7 57.0 69.6 72.2 46.8 77.2 86.1
mk10 104 6600 2.9 6.7 6.7 1.9 6.7 6.7 1.0 1.0 1.9
mk14 578 35 850 12.5 36.9 56.9 8.7 26.0 43.1 8.8 33.0 50.0
mp2k1 121 8148 24.0 31.4 37.2 19.8 23.1 39.7 19.8 21.5 28.1
plk1 107 6800 13.1 32.7 56.1 1.9 10.3 14.0 13.1 44.9 59.8
rock1 100 6300 0.0 0.0 0.0 2.0 6.0 16.0 4.0 9.0 11.0
src 524 34 494 31.7 61.8 73.1 13.2 27.9 38.2 17.2 33.6 46.4
tgfr1 133 8500 49.6 82.0 91.7 47.4 82.7 95.5 43.6 85.0 92.5
vgfr2 409 24 949 20.0 43.3 57.7 12.2 31.3 41.1 28.1 52.6 69.4
wee1 102 6149 61.8 90.2 90.2 61.8 91.2 92.2 61.8 90.2 91.2
a

Bold entries indicate best values for each category of percent recall (PR).

b

DISTRIB_FP_300 were computed by averaging fragment vectors obtained from skip-gram architecture.